Sun Shuo, Xue Jianming, Guo Yunfei, Li Jianling
The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
Front Genet. 2022 Dec 2;13:1072544. doi: 10.3389/fgene.2022.1072544. eCollection 2022.
Primary liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death worldwide in 2020, and it ranks fifth in global incidence. Liver resection or liver transplantation are the two most prominent surgical procedures for treating primary liver cancer. Both inevitably result in HIRI, causing severe complications for patients and affecting their prognosis and quality of survival. Ferroptosis, a newly discovered mode of cell death, is closely related to HIRI. We used bioinformatics analysis to explore the relationship between the two further. The GEO database dataset GSE112713 and the FerrDB database data were selected to use bioinformatic analysis methods (difference analysis, FRGs identification, GO analysis, KEGG analysis, PPI network construction and analysis, Hub gene screening with GO analysis and KEGG analysis, intergenic interaction prediction, drug-gene interaction prediction, miRNA prediction) for both for correlation analysis. The GEO database dataset GSE15480 was selected for preliminary validation of the screened Hub genes. We analysed the dataset GSE112713 for differential gene expression before and after hepatic ischemia-reperfusion and identified by FRGs, yielding 11 genes. These 11 genes were subjected to GO, and KEGG analyses, and PPI networks were constructed and analysed. We also screened these 11 genes again to obtain 5 Hub genes and performed GO analysis, KEGG analysis, intergenic interaction prediction, drug-gene interaction prediction, and miRNA prediction on these 5 Hub genes. Finally, we obtained preliminary validation of all these 5 Hub genes by dataset GSE15480. There is a close relationship between HIRI and ferroptosis, and inhibition of ferroptosis can potentially be a new approach to mitigate HIRI treatment in the future.
原发性肝癌是2020年全球第六大最常被诊断出的癌症,也是全球第三大致癌死亡原因,在全球发病率中排名第五。肝切除术或肝移植是治疗原发性肝癌最突出的两种外科手术。两者都不可避免地导致肝缺血再灌注损伤(HIRI),给患者带来严重并发症,并影响其预后和生存质量。铁死亡是一种新发现的细胞死亡模式,与HIRI密切相关。我们使用生物信息学分析进一步探究两者之间的关系。选择基因表达综合数据库(GEO数据库)数据集GSE112713和铁死亡相关数据库(FerrDB数据库)数据,运用生物信息学分析方法(差异分析、铁死亡相关基因(FRGs)鉴定、基因本体(GO)分析、京都基因与基因组百科全书(KEGG)分析、蛋白质-蛋白质相互作用(PPI)网络构建与分析、基于GO分析和KEGG分析的枢纽基因筛选、基因间相互作用预测、药物-基因相互作用预测、微小RNA(miRNA)预测)进行相关性分析。选择GEO数据库数据集GSE15480对筛选出的枢纽基因进行初步验证。我们分析数据集GSE112713肝缺血再灌注前后的差异基因表达,并通过FRGs鉴定出11个基因。对这11个基因进行GO和KEGG分析,并构建和分析PPI网络。我们还对这11个基因再次筛选,获得5个枢纽基因,并对这5个枢纽基因进行GO分析、KEGG分析、基因间相互作用预测、药物-基因相互作用预测和miRNA预测。最后,通过数据集GSE15480对所有这5个枢纽基因进行了初步验证。HIRI与铁死亡之间存在密切关系,抑制铁死亡可能成为未来减轻HIRI治疗的一种新方法。